|Articles|December 1, 2013

Review of the year 2013: Retina 2013

2013 has been an important year in retina therapy, with increased information released on nutritional supplements for AMD patients, widened indications for anti-VEGFs and the approval of treatment for symptomatic vitreomacular adhesion.

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Subscribe

Related Content

(Ophthalmology Times Europe) Lab bench to bedside to backpack: AI’s reach in retinal disease

AI's reach in retinal disease: Lab bench to bedside to backpack

BySheryl Stevenson

September 7th 2026

Effect of a maternal high-fat diet on the peripheral retina in mice

ByLynda Charters

August 12th 2026

Functional OCT takes retinal imaging where structure alone cannot go

ByAnat Loewenstein, MD, MHA,Sheryl Stevenson

July 25th 2026

Mikhail Boukhny and Andy Chang | Ophthalmology Times Europe

Hands-on training, real surgeon input: inside BVI's new Experience Hub

ByMikhail Boukhny,Andy Chang,Lucia Gambuzza

July 3rd 2026

Mulling over options for mitigating severe vision loss from diabetes

ByA. Paul Chous, MA, OD, FAAO

June 22nd 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Review of the year 2013: Retina 2013

Related Content

AI's reach in retinal disease: Lab bench to bedside to backpack

Effect of a maternal high-fat diet on the peripheral retina in mice

Functional OCT takes retinal imaging where structure alone cannot go

Hands-on training, real surgeon input: inside BVI's new Experience Hub

Mulling over options for mitigating severe vision loss from diabetes

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery